These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 1265473
1. The serum half-life and urine concentrations of cephazolin sodium in patients with terminal renal failure: effect of haemodialysis. Eastwood JB, Gower PE, Curtis JR. Scott Med J; 1976 Sep; 20(5):240-3. PubMed ID: 1265473 [Abstract] [Full Text] [Related]
4. Cefazolin in children with renal insufficiency. Hiner LB, Baluarte HJ, Polinsky MS, Gruskin AB. J Pediatr; 1980 Feb; 96(2):335-9. PubMed ID: 7351609 [Abstract] [Full Text] [Related]
5. Cephazolin: a comparison to ampicillin in respiratory and urinary infections with dosage regulation by a nomogram. Benner EJ, Kranhold JF, Bush WG. Scott Med J; 1976 Sep; 20(5):244-7. PubMed ID: 772809 [Abstract] [Full Text] [Related]
6. Cephazolin treatment of pneumococcal pneumonia and urinary tract infections. Kilpatrick M, Cesario TC, Thrupp L, Tilles JG. Scott Med J; 1976 Sep; 20(5):248-54. PubMed ID: 1265474 [Abstract] [Full Text] [Related]
7. Effect of renal failure and hemodialysis on cephacetrile pharmacokinetics. Nissenson AR, Levin NW, Parker RH. Clin Pharmacol Ther; 1972 Sep; 13(6):887-94. PubMed ID: 5081601 [No Abstract] [Full Text] [Related]
8. Cefazolin serum concentrations with fixed intravenous dosing in patients on chronic hemodialysis treatment. Kuypers D, Vanwalleghem J, Maes B, Messiaen T, Vanrenterghem Y, Peetermans WE. Nephrol Dial Transplant; 1999 Aug; 14(8):2050-1. PubMed ID: 10462306 [No Abstract] [Full Text] [Related]
9. Cephaloridine serum levels in patients on maintenance haemodialysis. Curtis JR, Marshall MJ. Br Med J; 1970 Apr 18; 2(5702):149-51. PubMed ID: 5440596 [Abstract] [Full Text] [Related]
10. Cefazolin dialytic clearance by high-efficiency and high-flux hemodialyzers. Sowinski KM, Mueller BA, Grabe DW, Manley HJ, Frye RF, Bailie GR, Marx MA. Am J Kidney Dis; 2001 Apr 18; 37(4):766-76. PubMed ID: 11273877 [Abstract] [Full Text] [Related]
11. Clinical pharmacology of cephalexin administered by intravenous injection. Davies JA, Holt JM. J Clin Pathol; 1972 Jun 18; 25(6):518-20. PubMed ID: 5043377 [Abstract] [Full Text] [Related]
13. [Serum concentrations and kinetics after intravenous infusion of four grams of cefazolin (author's transl)]. Adam D, Pätzold J. Infection; 1977 Jun 18; 5(4):228-31. PubMed ID: 598929 [Abstract] [Full Text] [Related]
14. [Serum levels of a new cephalosporin, cephacetrile, as a function of renal excretion capacity]. Brogard JM, Ruscher H, Frankhauser J, Kuntzmann F, Lavillaureix J. Pathol Biol (Paris); 1973 Jun 18; 21(6):671-9. PubMed ID: 4581199 [No Abstract] [Full Text] [Related]
15. An open-label, non-randomised, phase 1, single-dose study to assess the pharmacokinetics of ceftaroline in patients with end-stage renal disease requiring intermittent haemodialysis. Sunzel M, Learoyd M, Li J, Li Y, Ngo N, Edeki T. Int J Antimicrob Agents; 2015 Dec 18; 46(6):682-8. PubMed ID: 26545441 [Abstract] [Full Text] [Related]
16. Pharmacodynamics of practolol in chronic renal failure. Eastwood JB, Curtis JR, Smith RB. Br Med J; 1973 Nov 10; 4(5888):320-2. PubMed ID: 4758423 [Abstract] [Full Text] [Related]
17. Serum and plasma concentrations of clindamycin following a single intramuscular injection of clindamycin phosphate in maintenance haemodialysis patients and normal subjects. Roberts AP, Eastwood JB, Gower PE, Fenton CM, Curtis JR. Eur J Clin Pharmacol; 1978 Dec 18; 14(6):435-9. PubMed ID: 738351 [Abstract] [Full Text] [Related]
18. [Parenteral administration of a new cephalosporin in patients with chronic kidney failure. Study of plasmatic half-life of the antibiotic in relation to glomerular clearance]. Malandain H, Humbert G, Fillastre JP, Acar J, Dubois D, Leroy J, Robert M, Daufresne MF. Pathol Biol (Paris); 1973 Mar 18; 21(3):233-9. PubMed ID: 4574486 [No Abstract] [Full Text] [Related]
19. Pharmacokinetics of atenolol in patients with terminal renal failure and influence of haemodialysis. Flouvat B, Decourt S, Aubert P, Potaux L, Domart M, Goupil A, Baglin A. Br J Clin Pharmacol; 1980 Apr 18; 9(4):379-85. PubMed ID: 7378254 [Abstract] [Full Text] [Related]
20. Effect of hemodialysis on cefazolin protein binding. Greene DS, Tice AD. J Pharm Sci; 1977 Oct 18; 66(10):1508-10. PubMed ID: 925922 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]